Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 05, 2021

SELL
$102.91 - $122.75 $33,960 - $40,507
-330 Closed
0 $0
Q2 2021

Jul 09, 2021

SELL
$83.84 - $104.76 $4,024 - $5,028
-48 Reduced 12.7%
330 $34,000
Q2 2020

Jul 28, 2020

BUY
$57.54 - $76.95 $15,420 - $20,622
268 Added 243.64%
378 $26,000
Q1 2020

Apr 22, 2020

SELL
$52.41 - $81.0 $262 - $405
-5 Reduced 4.35%
110 $21,000
Q4 2019

Jan 22, 2020

BUY
$71.7 - $82.09 $8,245 - $9,440
115 New
115 $27,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Savior LLC Portfolio

Follow Savior LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savior LLC with notifications on news.